New research co-authored by researchers from Harvard T.H. Chan School of Public Health found seniors over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive innovative monoclonal antibody (mAbs) treatments.
But during the ongoing COVID-19 pandemic, anti-SARS-CoV-2 mAbs have been in short supply in the U.S., creating allocation conflicts at the local level.
Who Actually Receives Monoclonal Antibody Treatment?
Pandemic Preparedness Plan Targets Prototype and Priority Pathogens
As the global COVID-19 pandemic continues into its third year, the National Institute of Allergy and Infectious Diseases (NIAID) confirmed it is focusing on preparing for a range of other viral threats that could cause a public health emergency.
For decades, led by Director Anthony S. Fauci, M.D., the NIAID has launched research responses and developed medical countermeasures to combat emerging infectious diseases such as HIV/AIDS, Middle East respiratory syndrome, Ebola, Zika, SARS-CoV-1, and SARS-CoV-2 viruses.
Europe’s Digital COVID Certificate Extends to Summer of 2023
The European Commission (EC) announced a proposal on February 4, 2022, to extend the EU Digital COVID Certificate until June 30, 2023.
Currently, Member States must accept vaccination certificates for a period of nine months following the administration of the last dose of the primary vaccination.
‘The COVID-19 virus continues to be prevalent in Europe, and at this stage, it is not possible to determine the impact of a potential increase in infections in the second half of 2022 or of the emergence of new variants,’ stated the EC.
Homologous, Heterologous COVID-19 Boosters Are Immunogenic
Antibody neutralizing titers against SARS-CoV-2 D614G pseudovirus increased by factor of 4 to 73 for all combinations
CDC Backs Full Approval of Moderna COVID-19 Vaccine
Moderna vaccine is the second COVID-19 vaccine to receive full approval from both the FDA and CDC
Anti-RBD Antibodies Detected Up to 20 Months After COVID-19
99 percent of those with confirmed infection had anti-RBD antibodies versus 55 percent of those with unconfirmed infection
CVS, Walgreens Lift Limits on Purchases of Rapid COVID-19 Tests
Americans can also receive four free at-home tests directly from the U.S. government